COURTNEY SHEFFIELD: Open Payments
NPI 1467144501 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,615 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $1,222 · 2025 $1,615
Food & beverage: $1,615
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $381 |
| Kerecis Limited | 1 | $257 |
| AXOGEN | 2 | $228 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $164 |
| Amgen Inc. | 1 | $142 |
| Eisai Inc. | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| GENZYME CORPORATION | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $76 |
Products named: NATRELLE SALINE-FILLED BREAST IMPLANTS, Kerecis SurgiClose, TEPEZZA, Leqembi, DUPIXENT, Livdelzi.
Industry payments across TX — which companies pay providers there.
